|
WO2021069966A1
|
|
Methods, systems, and apparatuses for guiding transducer array placement
|
|
US2021060334A1
|
|
Delivering Tumor Treating Fields (TTFields) to the Neck
|
|
US2021038584A1
|
|
Increasing Cancer Cells' Sensitivity to Tumor Treating Fields (TTFields) by Inhibiting IL11 Activity
|
|
US2021031031A1
|
|
Applying Tumor Treating Fields (TTFields) Via Electrodes Embedded into Skull Implants
|
|
US2020372705A1
|
|
Methods, systems, and apparatuses for managing transducer array placement
|
|
US2020330755A1
|
|
Uploading Data from an Isolated System without Compromising Isolation
|
|
US2020306531A1
|
|
Methods for Restoring Sensitivity to TTFields in TTFields-Resistant Cancer Cells with PTGER3 Inhibitors
|
|
US2020269043A1
|
|
Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays
|
|
US2020269042A1
|
|
Determining a Frequency for TTFields Treatment Based on an Electrical Characteristic of Targeted Cancer Cells
|
|
US2020269041A1
|
|
Treating Gastric Cancer Using TTFields Combined with XELOX, FOLFOX or the Individual Constituents Thereof
|
|
US2020219261A1
|
|
Evaluating Quality of Segmentation of an Image into Different Types of Tissue for Planning Treatment Using Tumor Treating Fields (TTFields)
|
|
CA3110453A1
|
|
Enhanced-flexibility transducer arrays for delivering ttfields (tumor treating fields)
|
|
WO2020104921A1
|
|
Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements
|
|
US2020146586A1
|
|
Creating Accurate Computational Head Models of Patients Using Datasets Combining MRI and CT Images
|
|
WO2021050093A1
|
|
A method of reducing viability of cancer cells by applying alternating electric fields and administering checkpoint inhibitors to the cancer cells
|
|
US2020108031A1
|
|
Treating Tumors Using TTFields Combined with ABT-751
|
|
US2020078582A1
|
|
Treating Autoimmune Diseases Using an Alternating Electric Field to Reduce the Proliferation of T-Cells
|
|
BR112020025269A2
|
|
USE OF ENERGY LOSS DENSITY AND RELATED MEASURES TO QUANTIFY THE DOSE OF TUMOR TREATMENT FIELDS (TTFIELDS)
|
|
US2020016067A1
|
|
Methods and Compositions for Treating Tumors with TTFields and Sorafenib
|
|
SG11202012564SA
|
|
Inhibiting viral infection using alternating electric fields
|
